Viñes G - Search Results

1

[Detection of preclinical Cushing's syndrome in overweight type 2 diabetic patients].

Roubicek M, Isaac G, Viñes G. Roubicek M, et al. Among authors: vines g. Medicina (B Aires). 2001;61(1):116-7. Medicina (B Aires). 2001. PMID: 11265615 Spanish. No abstract available.

2

[Comparative study of glycosylated hemoglobin with oral glucose tolerance test in a selected population].

Viñes GB, Roubicek M, González Sanguineti A. Viñes GB, et al. Medicina (B Aires). 1998;58(6):728-32. Medicina (B Aires). 1998. PMID: 10347966 Spanish.

3

Use of HbA1c in screening for diabetes.

Roubicek M, Viñes G, González Sanguineti A. Roubicek M, et al. Among authors: vines g. Diabetes Care. 1998 Sep;21(9):1577-8; author reply 1578-9. doi: 10.2337/diacare.21.9.1577. Diabetes Care. 1998. PMID: 9727920 No abstract available.

4

Tests for diagnosing diabetes mellitus. Measuring glycated haemoglobin concentration is acceptable.

Roubicek M, González Sanguineti A, Viñes G. Roubicek M, et al. Among authors: vines g. BMJ. 1994 Aug 20-27;309(6953):537-8. BMJ. 1994. PMID: 8086916 Free PMC article. No abstract available.

5

[CAPTURE Study: Argentine results on prevalence of cardiovascular disease in type 2 diabetes mellitus].

Dieuzeide G, Waitman J, Pugnaloni Rodríguez NS, Rodríguez MV, Nardone L, Oviedo A; Grupo de Investigadores de Argentina del Estudio CAPTURE. Dieuzeide G, et al. Medicina (B Aires). 2022;82(3):398-407. Medicina (B Aires). 2022. PMID: 35639061 Free article. Spanish.

6

Hospitalization costs for heart failure in people with type 2 diabetes: cost-effectiveness of its prevention measured by a simulated preventive treatment.

Caporale JE, Elgart J, Pfirter G, Martínez P, Viñes G, Insúa JT, Gagliardino JJ. Caporale JE, et al. Among authors: vines g. Value Health. 2011 Jul-Aug;14(5 Suppl 1):S20-3. doi: 10.1016/j.jval.2011.05.018. Value Health. 2011. PMID: 21839892 Free article.

7

Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes.

Pitt B, Filippatos G, Agarwal R, Anker SD, Bakris GL, Rossing P, Joseph A, Kolkhof P, Nowack C, Schloemer P, Ruilope LM; FIGARO-DKD Investigators. Pitt B, et al. N Engl J Med. 2021 Dec 9;385(24):2252-2263. doi: 10.1056/NEJMoa2110956. Epub 2021 Aug 28. N Engl J Med. 2021. PMID: 34449181 Clinical Trial.

8

Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial.

Ruilope LM, Agarwal R, Anker SD, Bakris GL, Filippatos G, Nowack C, Kolkhof P, Joseph A, Mentenich N, Pitt B; FIGARO-DKD study investigators. Ruilope LM, et al. Am J Nephrol. 2019;50(5):345-356. doi: 10.1159/000503712. Epub 2019 Oct 30. Am J Nephrol. 2019. PMID: 31665733 Free PMC article. Clinical Trial.

9

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes.

Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Rossing P, Kolkhof P, Nowack C, Schloemer P, Joseph A, Filippatos G; FIDELIO-DKD Investigators. Bakris GL, et al. N Engl J Med. 2020 Dec 3;383(23):2219-2229. doi: 10.1056/NEJMoa2025845. Epub 2020 Oct 23. N Engl J Med. 2020. PMID: 33264825 Free article. Clinical Trial.

10

Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU).

Marre M, Shaw J, Brändle M, Bebakar WM, Kamaruddin NA, Strand J, Zdravkovic M, Le Thi TD, Colagiuri S; LEAD-1 SU study group. Marre M, et al. Diabet Med. 2009 Mar;26(3):268-78. doi: 10.1111/j.1464-5491.2009.02666.x. Diabet Med. 2009. PMID: 19317822 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters